Cardiothoracic Articles & Analysis
30 news found
“With this agreement and access to subspecialist radiologists, all non-tertiary located programs could instantly mature their cardiac, coronary, and pulmonary imaging offerings,” said Dr. Giovanni Lorenz, Lead Cardiothoracic Radiologist at DocPanel. “This is a game-changer for our ...
Joseph Coselli, MD (Professor, Executive Vice Chair, Division of Cardiothoracic Surgery, Baylor College of Medicine, Houston, Texas, US) the Principal Investigator commented: “This approval represents a significant milestone in the treatment of patients who need total aortic arch replacement and have significant disease of the descending thoracic aorta. ...
CytoSorb is also being used during and after cardiothoracic surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. ...
To begin with, we plan to highlight last year’s NICE Medtech innovation briefing on the use of CytoSorb to reduce the risk of bleeding during cardiothoracic surgery in patients on blood thinning medications in the UK health system. ...
The affiliation has continued in partnership with Michael Ma, MD, Assistant Professor of Cardiothoracic Surgery in the Division of Pediatric Cardiac Surgery at Stanford University, who has used and helped evolve the technology for the past several years. ...
CytoSorb is also being used during and after cardiothoracic surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. ...
With broad application in radio-guided surgery across multiple procedures and major cancer types, SENSEI is currently in use worldwide in prostate, cervical, and colorectal cancer surgery. Dr. Doug Adams, Cardiothoracic Surgeon, Bethesda North Hospital said, "Using SENSEI® was very straightforward with the da Vinci Xi. ...
Paul Sorajja, an interventional cardiologist at Abbott Northwestern Hospital and one of the implanting physicians in this trial commented, “Due to its unique leaflet design, DurAVR™ continues to provide superior haemodynamics with a balloon expandable platform”. Dr. Vinnie Bapat, a cardiothoracic surgeon at the Minneapolis Heart Institute and another member of ...
Wendt is Board-certified by the European Board of Cardiothoracic Surgery (FETCS) and also obtained his Master of Health Business Administration (MHBA) from the Friedrich-Alexander-University School of Business in Erlangen-Nuremberg, Germany. ...
CytoSorb is also being used during and after cardiothoracic surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. ...
The full Study enrollment will include plastic surgery, spinal surgery and cardiothoracic surgery closed incisions. The NPSIMS™, which contains no electrical or magnetic components, utilizes a novel solid-state chemical reaction to apply negative pressure to closed incisions. ...
If FDA marketing approval is obtained by the FDA, DrugSorb-ATR™ would be marketed in the United States for ticagrelor removal during urgent cardiothoracic surgery, with the intention of reducing the risk of bleeding. ...
When patients on various “blood thinners”, like apixaban or rivaroxaban, require urgent cardiothoracic surgery, the risk of serious or life-threatening bleeding and complications is very high. Based on our estimates, at least 1% of patients in the U.S. on apixaban or rivaroxaban may require urgent cardiothoracic surgery on an annual basis. Today ...
Overall, infective endocarditis is just one of many applications of our technology in cardiac surgery and is a much smaller opportunity than the removal of antithrombotic drugs during cardiothoracic surgery, for which we have specific approvals in the E.U., two U.S. ...
Schmitto and his interdisciplinary Heart Team of the Department of Cardiothoracic and Transplant Surgery (Director: Prof. Axel Haverich) at Hannover Medical School (Medizinische Hochschule Hannover – MHH), in Germany. ...
ByCarmat
Xeltis, a clinical-stage company with the most advanced polymer-based restorative cardiovascular devices, today announced that it has started the first-ever pivotal trial for a synthetic restorative pulmonary valve. To date, pediatric patients requiring right ventricular outflow tract (RVOT) reconstruction have been successfully implanted as part of the global, FDA-approved Xplore2/Pivotal study. ...
About AdjuCor AdjuCor is a Munich-based, German company that was founded as GmbH in 2012 by the cardiothoracic surgeon, Stephen Wildhirt. It has been funded by private investors, the European Union, as well as German and Bavarian entities. ...
“We are proud to be elevating our lung services across the OSF network with VIDA Insights,” said Kevin Fahey, MD, cardiothoracic radiologist, OSF HealthCare. “The breadth and complexity of lung diseases demand innovation for both diagnostic and therapeutic workflows. ...
“Detection and treatment of cardiac perforation or tamponade caused by epicardial leads is particularly problematic because these events, while rare, usually happen during lead removal outside of the operating room and in a setting with limited hemodynamic monitoring,” said Jordan Goldhammer, M.D., Cardiothoracic Anesthesiologist and Director of Cardiovascular ...
Over the last several years we have refined a set of techniques that are easily taught and reproduced,” said Chief of Cardiothoracic Surgery at Franciscan Health, Marc W. Gerdisch, MD. “Later this month, we will present on the experience from 15 institutions with 70 patients at the American Association for Thoracic Surgery Annual ...